期刊文献+
共找到42篇文章
< 1 2 3 >
每页显示 20 50 100
Potential value of detection of minimal residual disease in colorectal cancer following radical resection
1
作者 Wenji Pu Fang Chen +5 位作者 Yuan Tang Yanling Qu Yunzhu Han Jiandong Zha Jing Jin Fengming Kong 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2024年第4期442-454,共13页
Although there has been significant advancement in the identification and management of colorectal cancer(CRC)in recent years,there is still room for improvement in the current standard treatment regimen.One area of c... Although there has been significant advancement in the identification and management of colorectal cancer(CRC)in recent years,there is still room for improvement in the current standard treatment regimen.One area of concern is the lack of reliable tumor markers to predict treatment efficacy and guide tailored care.Due to its dynamic,effective,and non-invasive benefits over tissue biopsy,the detection of minimal or molecular residual lesions(MRD)based on circulating tumor DNA(ctDNA)is beneficial to the clinical development of drugs for patients with CRC after radical treatment,as well as for continuous monitoring of tumor recurrence and malignancy molecular gene evolution.The detection of ctDNA can currently be used to guide individual postoperative auxiliary treatment decisions(upgrade or downgrade treatment)in CRC,stratify the risk of clinical recurrence more precisely,and predict the risk of recurrence in advance of imaging examination,according to a large number of observational or prospective clinical studies.With increasing clarity comes the possibility of selecting a regimen of treatment based on postoperative ctDNA,which also improves the accuracy of clinical recurrence risk assessment for CRC.Therefore,it is anticipated that the identification of ctDNA would alter the current framework for dealing with CRC and lead to individualized,stratified precision therapy;however,additional confirmation will require subsequent high-quality,prospective,large-scale randomized controlled studies.This article will provide an overview of the definition and clinical significance of MRD,the primary indications and technological challenges for MRD detection,along with the advancement in clinical research about ctDNA detection following radical resection of the CRC. 展开更多
关键词 Colorectal cancer minimal residual disease circulating tumor DNA PROGNOSIS RECURRENCE biomarkers
下载PDF
Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma
2
作者 ALESSANDRO GOZZETTI MONICA BOCCHIA 《Oncology Research》 SCIE 2023年第3期271-274,共4页
Novel drug availability has increased the depth of response and revolutionised the outcomes of multiple myeloma patients.Minimal residual disease evaluation is a surrogate for progression-free survival and overall sur... Novel drug availability has increased the depth of response and revolutionised the outcomes of multiple myeloma patients.Minimal residual disease evaluation is a surrogate for progression-free survival and overall survival and has become widely used not-only in clinical trials but also in daily patient management.Bone marrow aspiration is the gold standard for response evaluation,but due to the patchy nature of myeloma,false negatives are possible.Liquid biopsy and blood-based minimal residual disease evaluation consider circulating plasma cells,mass spectrometry or circulating tumour DNA.This approach is less invasive,can provide a more comprehensive picture of the disease and could become the future of response evaluation in multiple myeloma patients. 展开更多
关键词 MYELOMA Liquid biopsy Minimal residual disease
下载PDF
Prognostic relevance of minimal residual disease in colorectal cancer 被引量:3
3
作者 Ulrich Bork Robert Grützmann +5 位作者 Nuh N Rahbari Sebastian Schlch Marius Distler Christoph Reissfelder Moritz Koch Jürgen Weitz 《World Journal of Gastroenterology》 SCIE CAS 2014年第30期10296-10304,共9页
Presence of occult minimal residual disease in patients with colorectal cancer(CRC)has a strong prognostic impact on survival.Minimal residual disease plays a major role in disease relapse and formation of metastases ... Presence of occult minimal residual disease in patients with colorectal cancer(CRC)has a strong prognostic impact on survival.Minimal residual disease plays a major role in disease relapse and formation of metastases in CRC.Analysis of circulating tumor cells(CTC)in the blood is increasingly used in clinical practice for disease monitoring of CRC patients.In this review article the role of CTC,disseminated tumor cells(DTC)in the bone marrow and micrometastases and isolated tumor cells(ITC)in the lymph nodes will be discussed,including literature published until September 2013.Occult disease is a strong prognostic marker for patient survival in CRC and defined by the presence of CTC in the blood,DTC in the bone marrow and/or micrometastases and ITC in the lymph nodes.Minimal residual disease could be used in the future to identify patient groups at risk,who might benefit from individualized treatment options. 展开更多
关键词 Colorectal cancer Circulating tumor cells Disseminated tumor cells Isolated tumor cells MICROMETASTASES Occult disease Minimal residual disease
下载PDF
High-precision downward continuation of potential fi elds algorithm utilizing adaptive damping coeffi cient of generalized minimal residuals 被引量:1
4
作者 Zhang Zhi-Hou Liao Xiao-Long +6 位作者 Shi Ze-Yu Lowry Anthony R. Yao Yu Lu Run-Qi Fan Xiang-Tai Liu Peng-Fei Zhao Si-Wei 《Applied Geophysics》 SCIE CSCD 2020年第5期672-686,900,共16页
The downward continuation of potential fields is a process of calculating their values in a lower plane based on those of a certain plane.This technology is not only a data processing method for resource exploration b... The downward continuation of potential fields is a process of calculating their values in a lower plane based on those of a certain plane.This technology is not only a data processing method for resource exploration but also plays an extremely important role in military applications.However,the downward continuation of potential fields is a typical linear inverse problem that is ill-posed.Generalized minimal residuals(GMRES)is an eff ective solution to ill-posed inverse problems,but it is unstable under the condition wherein the GMRES is directly applied in the calculation process.Moreover,the long-term behavior of its iterative computation is a disordered,divergent result.Therefore,to obtain stable solutions,GMRES is applied to solve the normal equations of the downward continuation of potential fields;it is also used to prequalify for occasional interruptions in the operation process by adding the damping coefficient,thus strengthening the stability conditions of the equations of residual minimization.Finally,the stable downward continuation of the potential fields method is proposed.As indicated by the theoretical data and the measured testing data,the method proposed in this paper has the advantages of high-precision and excellent stability.Furthermore,compared with the Tikhonov iteration method,the proposed method avoids the need to choose regularization parameters. 展开更多
关键词 Potential fi elds generalized minimal residual method high precision and stable downward continuation
下载PDF
Coexisting opportunities and challenges:In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer? 被引量:1
5
作者 Hanfei Guo Wenqian Li +3 位作者 Bin Wang Neifei Chen Lei Qian Jiuwei Cui 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2021年第5期574-582,共9页
Curative therapy was not previously available for patients with advanced non-small cell lung cancer(NSCLC);thus,the concept of minimal/measurable(or molecular)residual disease(MRD)was not applicable to these patients.... Curative therapy was not previously available for patients with advanced non-small cell lung cancer(NSCLC);thus,the concept of minimal/measurable(or molecular)residual disease(MRD)was not applicable to these patients.However,advances in targeted and immunotherapy have revolutionized the treatment landscape for patients with advanced NSCLC,with emerging evidence of long-term survival and even the hope of complete remission(CR)by imaging examination.The latest research shows that patients with oligometastatic lung cancer can benefit from local treatment.After removing the lesions,the choice of follow-up therapy and monitoring of the lesions could remain uncertain.MRD plays a role in identifying early-stage NSCLC patients with high risks of recurrence and determining adjuvant therapy after radical treatment.In recent years,evidence has been accumulating regarding the use of circulating cell-free tumor DNA(ctDNA)to assess MRD in solid tumors.This study discussed the possible applications of ctDNA-based MRD monitoring in advanced NSCLC and described the current challenges and unresolved problems in the application of MRD in advanced NSCLC. 展开更多
关键词 Minimal residual disease non-small cell lung cancer circulating tumor DNA
下载PDF
Improvement of the minimal residual method for solving nonsymmetric linear systems 被引量:1
6
作者 张居丽 蒋尔雄 《Journal of Shanghai University(English Edition)》 CAS 2007年第4期332-335,共4页
In this paper, the minimal residual (MRES) method for solving nonsymmetric equation systems was improved, the recurrence relation was deduced between the approximate solutions of the linear equation system Ax = b, a... In this paper, the minimal residual (MRES) method for solving nonsymmetric equation systems was improved, the recurrence relation was deduced between the approximate solutions of the linear equation system Ax = b, and a more effective method was presented, which can reduce the operational count and the storage. 展开更多
关键词 nonsymmetric matrix minimal residual (MRES) method the recurrence relation between approximate solutions.2000 Mathematics Subject Classification 65F10
下载PDF
CLINICAL SIGNIFICANCE OF THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD B-ALL BY FLOW CYTOMETRY 被引量:1
7
作者 沈立松 赵惠君 +3 位作者 徐翀 吴政宏 汤静燕 陈静 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2003年第2期100-104,111,共6页
Objective To detect the minimal residual disease in children with B-ALL and to evaluate its clinical significance by flow cytometry. Methods 58 childhood B-ALL cases were enrolled into this study and 33 MRD analyses w... Objective To detect the minimal residual disease in children with B-ALL and to evaluate its clinical significance by flow cytometry. Methods 58 childhood B-ALL cases were enrolled into this study and 33 MRD analyses were performed after remission induction therapy.Four-color combinations of fluorochrome labeled monoclonal antibodies against lymphocyte lineage related phenotypes were used to analyze leukemic cells with flow cytometry.The cells from normal bone marrow were used as controls.The combinations of phenotypes that reflect the antigen expression differences between leukemic and normal bone marrow cells on flow cytometry were considered to be the effective phenotype combinations in the first step screening.The effective phenotype combinations were then used to monitor MRD during the disease course after therapy began. Results 58 cases of childhood B-ALL were screened for MRD effective phenotype combinations.The effective phenotype combinations were identified in 89.7% of B-ALL cases in this study.Four-color phenotype combinations were composed of CD10/CD34/CD19 plus another effective marker such as CD38,CD58,CD66c,CD21.The senstitivity of this method was 0.01%,much higher than that of microscopic inspection.In 8 cases,their bone marrow microscopic inspection results showed no remaining leukemic cells;but with flow cytometry,the percentage of leukemic cells were 5.66%,0.36%,1.43%,0.069%,1.55%,2.7%,0.028% and 0.015%,respectively.In risk stratification,all these MRD positive cases were classified into high risk group for relapse and 1 case showed early relapse within 6 months. Conclusion The application of flow cytometry in MRD measurement can significantly improve the sensitivity of detection of remained leukemic cells in childhood B-ALL,and can provide more accurate information on disease progression as well as the efficacy of therapy,thus facilitate future treatment decisions and follow ups. 展开更多
关键词 B-ALL immunophenotyping minimal residual disease flow cytometry
下载PDF
DETECTION AND ITS CLINICAL VALUE OF MINIMAL RESIDUAL DISEASES IN ACUTE PROMYELOCYTIC LEUKEMIA
8
作者 姜国胜 唐天华 +10 位作者 毕可红 张玉昆 任海全 赵良玉 郭桂月 刘秀兰 任青华 姜枫勤 刘传芳 彭军 田志刚 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2002年第4期288-292,共5页
Objective: To detect the minimal residual diseases (MRD) in acute promyelocytic leukemia (APL) after complete remission (CR) and to analyze its clinical value in prognosis. Methods: Reverse transcription Polymerase ch... Objective: To detect the minimal residual diseases (MRD) in acute promyelocytic leukemia (APL) after complete remission (CR) and to analyze its clinical value in prognosis. Methods: Reverse transcription Polymerase chain reaction (RT/PCR) was used to detect MRD of patients with APL. Results: MRD positive rate in patients with APL was 92.8% (39/42) before treatment and 56.7 (21/37) immediately after the ATRA or chemotherapy-induced CR. Furthermore, MRD positive rate was related to the relapse in APL patients and could be considered as a marker to predict the relapse of patients with APL after CR. The MRD detection could also be applied to direct the consolidation therapy to prevent relapses. Conclusion: RT-PCR is valuable to monitor MRD and can be used as a marker to predict relapses. 展开更多
关键词 APL PCR Minimal residual disease
下载PDF
Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China:a retrospective multicenter study 被引量:3
9
作者 Huishou Fan Weida Wang +6 位作者 Ya Zhang Jianxiang Wang Tao Cheng Lugui Qiu Xin Wang Zhongjun Xia Gang An 《Cancer Biology & Medicine》 SCIE CAS CSCD 2023年第1期77-87,共11页
Objective:Evidence on the prognostic value of autologous stem cell transplantation(ASCT)and minimal residual disease(MRD)dynamics of patients with newly diagnosed multiple myeloma(NDMM)in China is limited.Our objectiv... Objective:Evidence on the prognostic value of autologous stem cell transplantation(ASCT)and minimal residual disease(MRD)dynamics of patients with newly diagnosed multiple myeloma(NDMM)in China is limited.Our objective in the current study was to understand the current care paradigm and outcomes of these patients.Methods:This longitudinal cohort study used historical data from three top-tier hematologic disease care hospitals that contributed to the National Longitudinal Cohort of Hematological Diseases-Multiple Myeloma.Treatment regimens[proteasome inhibitor(PI)-,immunomodulatory drug(IMiD)-,PI+IMiD-based,and conventional],post-induction response,ASCT and MRD status,and survival outcomes[progression-free survival(PFS)and overall survival(OS)]were evaluated.Results:In total,454 patients with NDMM were included(median age,57 years;59.0%males)with a median follow-up of 58.7 months.The overall response rate was 91.0%,83.9%,90.6%,and 60.9%for PI-,IMiD-,PI+IMiD-based,and conventional regimens,respectively.Patients with ASCT during first-line therapy(26.2%)had a longer PFS and OS than patients who did not receive ASCT[median PFS,42.9 vs.21.2 months,P<0.001;median OS,not reached(NR)vs.65.8 months,P<0.001].The median OS was NR,71.5,and 56.6 months among patients with sustained MRD negativity,loss of MRD negativity,and persistent MRD,respectively(P<0.001).Multivariate analysis revealed that the lactic dehydrogenase level,International Staging System stage,extra-medullary disease,and upfront ASCT were independent factors in predicting OS among NDMM patients.Conclusions:Our study showed that novel agent-based regimens,first-line ASCT,and sustained MRD negativity were associated with a superior outcome for patients with NDMM in China(Identifier:NCT04645199). 展开更多
关键词 Multiple myeloma autologous stem cell transplantation minimal residual disease survival outcomes multicenter study
下载PDF
Two-Parameter Block Triangular Splitting Preconditioner for Block Two-by-Two Linear Systems
10
作者 Bo Wu Xingbao Gao 《Communications on Applied Mathematics and Computation》 EI 2023年第4期1601-1615,共15页
This paper proposes a two-parameter block triangular splitting(TPTS)preconditioner for the general block two-by-two linear systems.The eigenvalues of the corresponding preconditioned matrix are proved to cluster aroun... This paper proposes a two-parameter block triangular splitting(TPTS)preconditioner for the general block two-by-two linear systems.The eigenvalues of the corresponding preconditioned matrix are proved to cluster around 0 or 1 under mild conditions.The limited numerical results show that the TPTS preconditioner is more efficient than the classic block-diagonal and block-triangular preconditioners when applied to the flexible generalized minimal residual(FGMRES)method. 展开更多
关键词 Block triangular splitting Block two-by-two linear systems Eigenvalues PRECONDITIONER flexible generalized minimal residual(FGMRES)
下载PDF
Current assessment and management of measurable residual disease in patients with acute lymphoblastic leukemia in the setting of CAR-T-cell therapy
11
作者 Minghao Lin Xiaosu Zhao +1 位作者 Yingjun Chang Xiangyu Zhao 《Chinese Medical Journal》 SCIE CAS CSCD 2024年第2期140-151,共12页
Chimeric antigen receptor(CAR)-modified T-cell therapy has achieved remarkable success in the treatment of acute lymphoblastic leukemia(ALL).Measurable/minimal residual disease(MRD)monitoring plays a significant role ... Chimeric antigen receptor(CAR)-modified T-cell therapy has achieved remarkable success in the treatment of acute lymphoblastic leukemia(ALL).Measurable/minimal residual disease(MRD)monitoring plays a significant role in the prognostication and management of patients undergoing CAR-T-cell therapy.Common MRD detection methods include flow cytometry(FCM),polymerase chain reaction(PCR),and next-generation sequencing(NGS),and each method has advantages and limitations.It has been well documented that MRD positivity predicts a poor prognosis and even disease relapse.Thus,how to perform prognostic evaluations,stratify risk based on MRD status,and apply MRD monitoring to guide individual therapeutic decisions have important implications in clinical practice.This review assesses the common and novel MRD assessment methods.In addition,we emphasize the critical role of MRD as a prognostic biomarker and summarize the latest studies regarding MRD-directed combination therapy with CAR-T-cell therapy and allogeneic hematopoietic stem cell transplantation(allo-HSCT),as well as other therapeutic strategies to improve treatment effect.Furthermore,this review discusses current challenges and strategies for MRD detection in the setting of disease relapse after targeted therapy. 展开更多
关键词 Measurable/minimal residual disease Acute lymphoblastic leukemia Chimeric antigen receptor-modified T-cell therapy Allogeneic hematopoietic stem cell transplantation RELAPSE
原文传递
The potential role of minimal/molecular residual disease in colorectal cancer: curative surgery, radiotherapy and beyond
12
作者 Meiyi Xu Tianhao Shi +2 位作者 Ruilian Xu Gong Chen Wan He 《Journal of the National Cancer Center》 2023年第3期203-210,共8页
Detection of minimal/molecular residual disease(MRD)based on ctDNA assay develops from hematological malignancies to solid tumors.Generally,there are two mainstream assays in MRD testing technology:tumor-informed and ... Detection of minimal/molecular residual disease(MRD)based on ctDNA assay develops from hematological malignancies to solid tumors.Generally,there are two mainstream assays in MRD testing technology:tumor-informed and tumor-agnostic.For colorectal cancer(CRC),MRD is used not only to monitor recurrence and predict prognosis,but also to help in clinical decision making and assessment of clinical efficacy in the settings of curative surgery,radiotherapy,chemotherapy and surveillance.Accumulated clinical trials are exploring roles of MRD in early or advanced stages of CRC.Here,we give an overview of how MRD is and will be used in CRC. 展开更多
关键词 Minimal/molecular residual disease CtDNA Colorectal cancer
下载PDF
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions 被引量:6
13
作者 Sakti Chakrabarti Carrie Y Peterson +1 位作者 Deepika Sriram Amit Mahipal 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2020年第8期808-832,共25页
Colon cancer continues to be one of the leading causes of mortality and morbidity throughout the world despite the availability of reliable screening tools and effective therapies.The majority of patients with colon c... Colon cancer continues to be one of the leading causes of mortality and morbidity throughout the world despite the availability of reliable screening tools and effective therapies.The majority of patients with colon cancer are diagnosed at an early stage(stages I to III),which provides an opportunity for cure.The current treatment paradigm of early stage colon cancer consists of surgery followed by adjuvant chemotherapy in a select group of patients,which is directed at the eradication of minimal residual disease to achieve a cure.Surgery alone is curative for the vast majority of colon cancer patients.Currently,surgery and adjuvant chemotherapy can achieve long term survival in about two-thirds of colon cancer patients with nodal involvement.Adjuvant chemotherapy is recommended for all patients with stage III colon cancer,while the benefit in stage II patients is not unequivocally established despite several large clinical trials.Contemporary research in early stage colon cancer is focused on minimally invasive surgical techniques,strategies to limit treatment-related toxicities,precise patient selection for adjuvant therapy,utilization of molecular and clinicopathologic information to personalize therapy and exploration of new therapies exploiting the evolving knowledge of tumor biology.In this review,we will discuss the current standard treatment,evolving treatment paradigms,and the emerging biomarkers,that will likely help improve patient selection and personalization of therapy leading to superior outcomes. 展开更多
关键词 ADJUVANT Circulating tumor DNA Immunoscore Minimally invasive NEOADJUVANT FOxTROT Minimal residual disease International duration evaluation of adjuvant chemotherapy
下载PDF
Squamous cell carcinoma of the oral cavity and circulating tumour cells 被引量:8
14
作者 Johannes Wikner Alexander Grobe +1 位作者 Klaus Pantel Sabine Riethdorf 《World Journal of Clinical Oncology》 CAS 2014年第2期114-124,共11页
Due to a lack of substantial improvement in the outcome of patients suffering from oral squamous cell carcinoma(OSCC) during the past decades, current staging methods need to be revised. This disease is associated wit... Due to a lack of substantial improvement in the outcome of patients suffering from oral squamous cell carcinoma(OSCC) during the past decades, current staging methods need to be revised. This disease is associated with poor survival rates despite considerable advances in diagnosis and treatment. The early detection of metastases is an important indicator of survival, prognosis and relapse. Therefore, a better understanding of the mechanisms underlying metastasis is crucial. Exploring alternative measures apart from common procedures is needed to identify new prognostic markers. Similar to previous findings predominantly for other solid tumours, recently published studies demonstrate that circulating tumour cells(CTCs) and disseminated tumour cells(DTCs) might serve as prognostic markers and could supplement routine staging in OSCC. Thus, the detection of CTCs/DTCs is a promising tool todetermine the individual need for therapeutic intervention. Encouraging results and new approaches point to the future use of targeted therapies for OSCC, an exceedingly heterogeneous subgroup of head and neck cancer. This review focuses on summarising technologies currently used to detect CTCs/DTCs. The translational relevance for OSCC is highlighted. The inherent challenges in detecting CTCs/DTCs will be emphasised. 展开更多
关键词 Circulating tumour cells Disseminated tumour cells Oral squamous cell carcinoma Head and neck squamous cell carcinoma Bone marrow Peripheral blood MICROMETASTASIS Minimal residual disease Epithelial-mesenchymal transition
下载PDF
Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance 被引量:9
15
作者 Gang Wang Fang-Ying Ning +4 位作者 Jia-Heng Wang Hai-Meng Yan Hong-Wei Kong Yu-Ting Zhang Qiang Shen 《World Journal of Clinical Cases》 SCIE 2019年第24期4234-4244,共11页
BACKGROUND The guiding effect of prognostic stratification in multiple myeloma(MM) for treatment has been increasingly emphasized in recent years. The stratification of risk factors based on the International Staging ... BACKGROUND The guiding effect of prognostic stratification in multiple myeloma(MM) for treatment has been increasingly emphasized in recent years. The stratification of risk factors based on the International Staging System(ISS), Durie-Salmon(DS)staging and related indicators is affected by the renal function of patients,resulting in poor performance. This study assesses the relationship between interleukin-32(IL-32) and related risk factors in 67 patients with MM and their clinical outcomes.AIM To investigate the feasibility of IL-32 in evaluating prognosis in patients with MM and the factors influencing prognosis.METHODS This was a pragmatic, prospective observational study of patients with MM at a single center. According to IL-32 level, patients were divided into two groups.The variables under consideration included age, blood β2-microglobulin,albumin, C-reactive protein, serum calcium, serum creatinine, lactate dehydrogenase, M protein type, ISS stage, DS stage, and IL-32 levels and minimal residual disease(MRD) after induction treatment. The main outcomes were progression-free survival(PFS) and overall survival(OS).RESULTS IL-32 was an important factor affecting PFS and OS in patients with MM.Compared with patients with IL-32 levels ≥ 856.4 pg/m L, patients with IL-32 levels < 856.4 pg/m L had longer PFS(P = 0.0387) and OS(P = 0.0379);Univariate analysis showed that IL-32 level and MRD were significantly associated with OS and PFS(P < 0.05). Multivariate analysis showed that IL-32 levels ≥ 856.4 pg/m L and MRD positive were still independent risk factors for OS and PFS(P < 0.05).CONCLUSION IL-32 is valuable for assessing the prognosis of MM patients. IL-32 level combined with MRD may be a useful routine evaluation index for MM patients after treatment. 展开更多
关键词 Multiple myeloma INTERLEUKIN-32 Minimal residual lesions Progression-free survival Overall survival Prognosis
下载PDF
Jacobian-free Newton-Krylov subspace method with wavelet-based preconditioner for analysis of transient elastohydrodynamic lubrication problems with surface asperities 被引量:1
16
作者 N.M.BUJURKE M.H.KANTLI 《Applied Mathematics and Mechanics(English Edition)》 SCIE EI CSCD 2020年第6期881-898,共18页
This paper presents an investigation into the effect of surface asperities on the over-rolling of bearing surfaces in transient elastohydrodynamic lubrication(EHL) line contact. The governing equations are discretized... This paper presents an investigation into the effect of surface asperities on the over-rolling of bearing surfaces in transient elastohydrodynamic lubrication(EHL) line contact. The governing equations are discretized by the finite difference method. The resulting nonlinear system of algebraic equations is solved by the Jacobian-free Newtongeneralized minimal residual(GMRES) from the Krylov subspace method(KSM). The acceleration of the GMRES iteration is accomplished by a wavelet-based preconditioner.The profiles of the lubricant pressure and film thickness are obtained at each time step when the indented surface moves through the contact region. The prediction of pressure as a function of time provides an insight into the understanding of fatigue life of bearings.The analysis confirms the need for the time-dependent approach of EHL problems with surface asperities. This method requires less storage and yields an accurate solution with much coarser grids. It is stable, efficient, allows a larger time step, and covers a wide range of parameters of interest. 展开更多
关键词 transient elastohydrodynamic lubrication(EHL) surface roughness bearing Newton-Krylov method generalized minimal residual(GMRES) wavelet preconditioner
下载PDF
Predictive Value of Dynamic Peri-Transplantation MRD Assessed By MFC Either Alone or in Combination with Other Variables for Outcomes of Patients with T-Cell Acute Lymphoblastic Leukemia 被引量:1
17
作者 Zhi-dong WANG Yue-wen WANG +15 位作者 Lan-ping XU Xiao-hui ZHANG Yu WANG Huan CHEN Yu-hong CHEN Feng-rong WANG Wei HAN Yu-qian SUN Chen-hua YAN Fei-fei TANG Xiao-dong MO Ya-zhe WANG Yan-rong LIU Kai-yan LIU Xiao-jun HUANG Ying-jun CHANG 《Current Medical Science》 SCIE CAS 2021年第3期443-453,共11页
We performed a retrospective analysis to investigate dynamic peri-hematopoieticstem cell transplantation(HSCT)minimal/measurable residual disease(MRD)on outcomes inpatients with T-cell acute lymphoblastic leukemia(T-A... We performed a retrospective analysis to investigate dynamic peri-hematopoieticstem cell transplantation(HSCT)minimal/measurable residual disease(MRD)on outcomes inpatients with T-cell acute lymphoblastic leukemia(T-ALL).A total of 271 patients were enrolledand classified into three groups:unchanged ncgative MRD pre-and post-HSCT group(group A),post-MRD non-increase group(group B),and post-MRD increase group(group C).The patientsin group B and group C experienced a higher cumulative incidence of relapse(CIR)(42%vs.71%vs.16%,P<0.001)and lower leukemia-free survival(LFS)(46%vs.21%vs.70%,P<0.001)andoverall survival(OS)(50%vs.28%vs.72%,P<0.001)than in group A,but there was no significantdifference in non-relapse mortality(NRM)among three groups(14%vs.12%vs.8%,P=0.752).Multivariate analysis showed that dynamic peri-HSCT MRD was associated with CIR(HR=2.392,95%CI,1.816-3.151,P<0.001),LFS(HR=1.964,95%CI,1.546-2.496,P<0.001)and os(HR=1.731,95%CI,1.348-2.222,P<0.001).We also established a risk scoring system based ondynamic peri-HSCT MRD combined with remission status pre-HSCT and onsct of chronic graft-versus-host disease(GVHD).This risk scoring system could better distinguish ClR(c=0.730)thanthat for pre-HSCT MRD(c=0.562),post-HSCT MRD(c=0.616)and pre-and post-MRD dynamics(c=0.648).Our results confirm the outcome predictive value of dynamic peri-HSCT MRD eitheralone or in combination with other variables for patients with T-ALL. 展开更多
关键词 peri-transplantation minimal residual disease risk stratification risk scoring system T-cell acute lymphoblastic leukemia
下载PDF
PRAME Gene Expression in Acute Leukemia and Its Clinical Significance 被引量:1
18
作者 Kai Ding Xiao-ming Wang +3 位作者 Rong Fu Er-bao Ruan Hui Liu Zong-hong Shao 《Clinical oncology and cancer researeh》 CAS CSCD 2012年第1期73-76,共4页
Objective To investigate the expression of the preferentially expressed antigen of melanoma (PRAME) gene in acute leukemia and its clinical significance. Methods The level of expressed PRAME mRNA in bone marrow mono... Objective To investigate the expression of the preferentially expressed antigen of melanoma (PRAME) gene in acute leukemia and its clinical significance. Methods The level of expressed PRAME mRNA in bone marrow mononuclear cells from 34 patients with acute leukemia (AL) and in 12 bone marrow samples from healthy volunteers was measured via RT-PCR. Correlation analyses between PRAME gene expression and the clinical characteristics (gender, age, white blood count, immunophenotype of leukemia, percentage of blast cells, and karyotype) of the patients were performed. Results The PRAME gene was expressed in 38.2% of all 34 patients, in 40.7% of the patients with acute myelogenous leukemia (AML, n=27), and in 28.6% of the patients with acute lymphoblastic leukemia (ALL, n=7), but was not expressed in the healthy volunteers. The difference in the expression levels between AML and ALL patients was statistically significant. The rate of gene expression was 80% in M~, 33.3% in M2, and 28.6% in M~. Gene expression was also found to be correlated with CDl5 and CD33 expression and abnormal karyotype, but not with age, gender; white blood count or percentage of blast cells. Conclusions The PRAME gene is highly expressed in acute leukemia and could be a useful marker to monitor minimal residual disease. This gene is also a candidate target for the immunotherapy of acute leukemia. 展开更多
关键词 preferentially expressed antigen of melanoma GENE acute leukemia minimal residual disease IMMUNOTHERAPY
下载PDF
Detection and clinical significance of multidrug resistance-1 mRNA in bone marrow cells in children with acute lymphoblastic leukemia by real-time fluorescence quantitative RT-PCR 被引量:1
19
作者 Yuan Lu Runming Jin +3 位作者 Kun Yang Lirong Sun Yan Xia Xiuying Pang 《Journal of Nanjing Medical University》 2008年第3期153-158,共6页
Objective: Multidrug resistance(MDR) is one of the most important reasons for treatment failure and recurrence of acute leukemia. Its manifestations are different in children with acute lymphoblastic leukemia(ALL... Objective: Multidrug resistance(MDR) is one of the most important reasons for treatment failure and recurrence of acute leukemia. Its manifestations are different in children with acute lymphoblastic leukemia(ALL) which may be due to different detection methods. This study was to detect the expression of MDR1 mRNA in bone marrow cells of children with ALL by real-time fluorescence- quantitative reverse transcription polymerase-chain reaction(FQ-RT-PCR), and combine minimal residual desease(MRD) detection by flow cytometry(FCM) and to study their relationship with treatment response and prognosis of ALL. Methods:The MDR1 mRNA levels in bone marrow cells from 67 children with ALL[28 had newly diagnosed disease, 27 had achieved complete remission(CR), 12 recurrent] and 22 children without leukemia were detected by FQ-RT-PCR. MRD was detected by FCM. The patients were observed for 9-101 months, with a median of 64 months. Results:Standard curves of human MDR1 and GAPDH genes were constructed successfully. MDR1 mRNA was detected in all children with a positive rate of 100%. The mRNA level of MDR1 was similar among the newly diagnosed ALL group, CR group, and control group(P 〉 0.05), but significantly higher in the recurrence group than that in newly diagnosed disease group and control group(0.50 ± 0.55 vs. 0.09 ± 0.26 and 0.12 ± 0.23, P〈 0.05). 54 ALL patients were followed up, and it was found that MDR1 mRNA level was significantly higher in ALL patients within 3 years duration than that of ALL patients with 3-6 years and over 6 years duration(0.63 ± 0.56 vs. 0.11 ± 0.12 and 0.04 ± 0.06, P〈 0.01). For the 28 children with newly diagnosed disease, the MDR1 mRNA level was similar between WBC 〉 50 ~ 109 group and WBC〈50 × 10^9 group(P〉 0.05). In the 33 CR patients, the MDR1 mRNA level was significantly higher in MRD〉10a group than that in MRD〈10a group(0.39 ± 0.47 vs. 0.03 ± 0.03, P 〈 0.05). Conclusion:The sensitivity and specificity of FQ-RT-PCR in detecting MDR1 mRNA in bone marrowy cells of children with ALL patients are high. MDR1 mRNA is expressed in children with and without leukemia. MDR1 mRNA is highly expressed in the CR ALL patients with high MRD, recurrence and short duration(within 3 years). Monitoring MRD and the MDR1 mRNA level might be helpful for individual treatment. 展开更多
关键词 LEUKEMIA CHILDREN multidrug resistance MDR1 gene minimal residual disease real-time fluorescence quantitative RT-PCR
下载PDF
THE RELATIONSHIP BETWEEN NON-HODGKIN'S LYMPHOMA AND THE GENE REARRANGEMENT
20
作者 郭素堂 刘永昌 孙俊宁 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1998年第4期73-76,共4页
Objective: To investigate the pattern of clonal rearrangement of immunoglobulin heavy chain gene (IGH) and T cell receptor γ gene (TCRγ) of Non Hodgkin's lymphoma (NHL) Methods: Bone marrow smears of 211 pat... Objective: To investigate the pattern of clonal rearrangement of immunoglobulin heavy chain gene (IGH) and T cell receptor γ gene (TCRγ) of Non Hodgkin's lymphoma (NHL) Methods: Bone marrow smears of 211 patients of NHL were detected by PCR, the rearranged IGH and TCRγ gene was amplified using oligonucleotide primers Results: The clonal rearrangement of IGH gene was detectable in 51 2% (108/211); the clonal rearrangement of TCRγ gene was detectable in 21 3% (45/211); both IGH and TCRγ was detectable in 5 7% (12/211); no clonal rearrangement in 21 8% (46/211) And compared clonal gene rearrangement with pathological type and primary site of tumor Ten patients of NHL were investigated serially 5/10 patients still had clonal gene rearrangement at clinical complete remission Conclusion: It demonstrated that this assay may be useful in monitoring the minimal residual disease (MRD) and in evaluating effectiveness of therapy 展开更多
关键词 NHL Clonal gene rearrangement Minimal residual disease IGH TCRγ
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部